Ji-Hyun Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ji-Hyun Bae has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Byeong-Hoon Cho
Department of Conservative Dentistry, Seoul National University School of Dentistry and Dental Research Institute, Seoul, Korea
1 shared publication - Ji-Young Yoon
Department of Conservative Dentistry, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea
1 shared publication Jong-Hwa Kim
Department of Oral and Maxillofacial Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
1 shared publication- Pil-Young Yun
Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
1 shared publication - Sang-Yun Kim
Department of Oral and Maxillofacial Surgery, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
1 shared publication - Seung-Kwon Myung
Department of Public Health & AI, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 6 August 2018
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
- Vol. 40 (1) , 21
Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study
The purpose of this study was to evaluate the clinical outcomes of treatment of non-odontogenic atypical orofacial pain using botulinum toxin-A. This study involved seven patients (seven females, mean age 65.1 years) who had non-odontogenic orofacial pain (neuropathic pain and atypical orofacial pain) and visited the Seoul National University Bundang Hospital between 2015 and 2017. All medication therapies were preceded by botulinum toxin-A injections, followed by injections in the insignificant effects of medication therapies. Five of the seven patients received intraoral injections in the gingival vestibule or mucosa, while the remaining two received extraoral injections in the masseter and temporal muscle areas. In five of the seven patients, pain after botulinum toxin-A injection was significantly reduced. Most of the patients who underwent surgery for dental implantation or facial nerve reconstruction recovered after injections. However, the pain did not disappear in two patients who reported experiencing persistent pain without any cause. The use of botulinum toxin-A for the treatment of non-odontogenic neuropathic orofacial pain is clinically useful. It is more effective to administer botulinum toxin-A in combination with other medications and physical therapy to improve pain.
- 6 August 2018
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
- Vol. 40 (1) , 21
Open AccessTreatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study
The purpose of this study was to evaluate the clinical outcomes of treatment of non-odontogenic atypical orofacial pain using botulinum toxin-A. This study involved seven patients (seven females, mean age 65.1 years) who had non-odontogenic orofacial pain (neuropathic pain and atypical orofacial pain) and visited the Seoul National University Bundang Hospital between 2015 and 2017. All medication therapies were preceded by botulinum toxin-A injections, followed by injections in the insignificant effects of medication therapies. Five of the seven patients received intraoral injections in the gingival vestibule or mucosa, while the remaining two received extraoral injections in the masseter and temporal muscle areas. In five of the seven patients, pain after botulinum toxin-A injection was significantly reduced. Most of the patients who underwent surgery for dental implantation or facial nerve reconstruction recovered after injections. However, the pain did not disappear in two patients who reported experiencing persistent pain without any cause. The use of botulinum toxin-A for the treatment of non-odontogenic neuropathic orofacial pain is clinically useful. It is more effective to administer botulinum toxin-A in combination with other medications and physical therapy to improve pain.
- Open Access
- 1 January 2018
- Published by Korean Academy of Conservative Dentistry in Restorative Dentistry & Endodontics
- Vol. 43 (2) , e16
Anatomical analysis of the resected roots of mandibular first molars after failed non-surgical retreatment
Yoon J, et al. Restor Dent Endod. 2018 Mar;43(2):e16. https://doi.org/10.5395/rde.2018.43.e16
- 1 January 2018
- Published by Korean Academy of Conservative Dentistry in Restorative Dentistry & Endodontics
- Vol. 43 (2) , e16
Open AccessAnatomical analysis of the resected roots of mandibular first molars after failed non-surgical retreatment
Yoon J, et al. Restor Dent Endod. 2018 Mar;43(2):e16. https://doi.org/10.5395/rde.2018.43.e16
- 9 January 2015
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 42 (2) , 131-141
Desensitizing toothpaste versus placebo for dentin hypersensitivity: a systematic review and meta‐analysis
Aim: The aim is to assess the effect of desensitizing toothpaste on dentin hypersensitivity.Methods: We searched PubMed, CENTRAL, and Embase on December 20, 2013.Results: Out of the 626 articles searched, a total of 31 randomized controlled clinical trials were included. The Standardized mean differences (SMD) for potassium‐containing toothpaste (n = 8) was −1.28 (95% Confidence interval (CI) −2.05 to −0.51; I2 = 93%); Stannous fluoride‐ (n = 6) was −1.37 (95% CI, −2.30 to −0.44; I2 = 95%); Potassium and stannous fluoride‐ (n = 3) was −2.50 (95% CI, −4.10 to −0.91; I2 = 95%); Calcium sodium phosphosilicate‐ (n = 4) was −2.36 (95% CI, −3.72 to −1.00; I2 = 92%); Arginine‐ (n = 8) was −3.25 (95% CI, −3.87 to −2.63; I2 = 86%). The desensitizing effect was favoured in the intervention group treated with potassium‐, stannous fluoride‐, potassium and stannous fluoride‐, calcium sodium phosphosilicate‐, and arginine‐containing toothpaste compared to placebo. Whereas, strontium‐containing toothpaste (SMD, 0.05; 95% CI, −0.34 to 0.44; I2 = 64%) was found to have no statistically significant desensitizing effect in the meta‐analysis of four studies.Conclusions: The study reports that there is sufficient evidence to support the use of potassium‐, stannous fluoride‐, potassium and stannous fluoride‐, calcium sodium phosphosilicate‐, and arginine‐containing desensitizing toothpastes for dentin hypersensitivity, but not the use of strontium‐containing desensitizing toothpaste.
- 9 January 2015
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 42 (2) , 131-141
Desensitizing toothpaste versus placebo for dentin hypersensitivity: a systematic review and meta‐analysis
Aim: The aim is to assess the effect of desensitizing toothpaste on dentin hypersensitivity.Methods: We searched PubMed, CENTRAL, and Embase on December 20, 2013.Results: Out of the 626 articles searched, a total of 31 randomized controlled clinical trials were included. The Standardized mean differences (SMD) for potassium‐containing toothpaste (n = 8) was −1.28 (95% Confidence interval (CI) −2.05 to −0.51; I2 = 93%); Stannous fluoride‐ (n = 6) was −1.37 (95% CI, −2.30 to −0.44; I2 = 95%); Potassium and stannous fluoride‐ (n = 3) was −2.50 (95% CI, −4.10 to −0.91; I2 = 95%); Calcium sodium phosphosilicate‐ (n = 4) was −2.36 (95% CI, −3.72 to −1.00; I2 = 92%); Arginine‐ (n = 8) was −3.25 (95% CI, −3.87 to −2.63; I2 = 86%). The desensitizing effect was favoured in the intervention group treated with potassium‐, stannous fluoride‐, potassium and stannous fluoride‐, calcium sodium phosphosilicate‐, and arginine‐containing toothpaste compared to placebo. Whereas, strontium‐containing toothpaste (SMD, 0.05; 95% CI, −0.34 to 0.44; I2 = 64%) was found to have no statistically significant desensitizing effect in the meta‐analysis of four studies.Conclusions: The study reports that there is sufficient evidence to support the use of potassium‐, stannous fluoride‐, potassium and stannous fluoride‐, calcium sodium phosphosilicate‐, and arginine‐containing desensitizing toothpastes for dentin hypersensitivity, but not the use of strontium‐containing desensitizing toothpaste.
- Open Access
- 1 January 2013
- Published by The Korean Association of Oral and Maxillofacial Surgeons in Journal of the Korean Association of Oral and Maxillofacial Surgeons
- Vol. 39 (2) , 77-84
Retrospective clinical study on sinus bone graft and tapered-body implant placement
Kim JH, et al. J Korean Assoc Oral Maxillofac Surg. 2013 Apr;39(2):77-84. http://dx.doi.org/10.5125/jkaoms.2013.39.2.77
- 1 January 2013
- Published by The Korean Association of Oral and Maxillofacial Surgeons in Journal of the Korean Association of Oral and Maxillofacial Surgeons
- Vol. 39 (2) , 77-84
Open AccessRetrospective clinical study on sinus bone graft and tapered-body implant placement
Kim JH, et al. J Korean Assoc Oral Maxillofac Surg. 2013 Apr;39(2):77-84. http://dx.doi.org/10.5125/jkaoms.2013.39.2.77